InspireMD, Inc.
NSPR
$1.94
-$0.04-2.02%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.52M | 1.78M | 1.53M | 1.95M | 1.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.52M | 1.78M | 1.53M | 1.95M | 1.81M |
| Cost of Revenue | 1.66M | 1.47M | 1.24M | 1.48M | 1.40M |
| Gross Profit | 864.00K | 313.00K | 292.00K | 469.00K | 414.00K |
| SG&A Expenses | 10.28M | 9.50M | 7.69M | 6.14M | 4.96M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.57M | 14.80M | 12.99M | 11.32M | 10.27M |
| Operating Income | -13.05M | -13.02M | -11.46M | -9.37M | -8.46M |
| Income Before Tax | -12.71M | -13.15M | -11.17M | -9.12M | -7.89M |
| Income Tax Expenses | -- | -- | -- | 59.00K | -- |
| Earnings from Continuing Operations | -12.71M | -13.15M | -11.17M | -9.17M | -7.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.71M | -13.15M | -11.17M | -9.17M | -7.89M |
| EBIT | -13.05M | -13.02M | -11.46M | -9.37M | -8.46M |
| EBITDA | -12.92M | -12.91M | -11.36M | -9.29M | -8.39M |
| EPS Basic | -0.17 | -0.26 | -0.22 | -0.19 | -0.16 |
| Normalized Basic EPS | -0.11 | -0.16 | -0.14 | -0.12 | -0.10 |
| EPS Diluted | -0.17 | -0.26 | -0.22 | -0.19 | -0.16 |
| Normalized Diluted EPS | -0.11 | -0.16 | -0.14 | -0.12 | -0.10 |
| Average Basic Shares Outstanding | 73.47M | 51.00M | 49.99M | 48.89M | 48.37M |
| Average Diluted Shares Outstanding | 73.47M | 51.00M | 49.99M | 48.89M | 48.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |